wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38391533-C0863EED-893A-4104-B37B-0C0A955E8F76
Q38391533-C0863EED-893A-4104-B37B-0C0A955E8F76
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38391533-C0863EED-893A-4104-B37B-0C0A955E8F76
On being less tolerant: enhanced cancer immunosurveillance enabled by targeting checkpoints and agonists of T cell activation.
P2860
Q38391533-C0863EED-893A-4104-B37B-0C0A955E8F76
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38391533-C0863EED-893A-4104-B37B-0C0A955E8F76
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ef87e210e820e0548695b021dc519425a58d4422
P2860
A phase I study of IMP321 and gemcitabine as the front-line therapy in patients with advanced pancreatic adenocarcinoma